Deferred settlements stretch the payments into FY28 while 80% of FY27 revenue is already presold
Cedar Woods Properties (ASX:CWP) has used a softer property market to do something most developers cannot right now. It is buying. The company has just announced three site acquisitions across Queensland and Victoria worth roughly $63 million, with two more in Western Australia advancing through due diligence.
The headline deals are a $30.85 million townhouse site at Kealba in Victoria, a $27.25 million apartment site at Fairfield in Brisbane, and a $5.32 million land parcel at South Maclean adjoining the existing Flourish community. Between them, they add roughly 750 future dwellings to the pipeline. The Kealba and Fairfield settlements are deferred into mid-FY28 and mid-FY27 respectively, which matters more than the headline numbers suggest.
Managing Director Nathan Blackburne flagged the obvious reason this is happening now. Bidder numbers have thinned out. When fewer developers can stomach land acquisitions because their balance sheets are stretched, the ones who can still write cheques get to set the price. Cedar Woods is doing exactly that.
The catch sits inside the same release. Fourth quarter enquiry and sales have softened on rising interest rates and lower stock availability, even as the company reaffirms it will hit the top end of its FY26 NPAT growth guidance of 30% to 35%.
Why the deferred settlement structure is the real story
The most important detail in this announcement is not the dollar value. It is the timing. Kealba settles mid-FY28 and Fairfield settles mid-FY27, which means Cedar Woods has effectively locked in pipeline replenishment without writing the cheques today.
That structure does two useful things at once. It preserves balance sheet capacity for the FY26 and FY27 delivery cycle, where capital is already committed to current projects. And it transfers some of the cycle-timing risk back to the vendors, who are accepting deferred payments because they have fewer alternative buyers.
We think this is the part of the announcement institutional investors will focus on. Buying counter-cyclically only works if you do not blow up the balance sheet doing it. Deferred terms are how Cedar Woods is threading that needle.
The presales book is doing the heavy lifting on near-term earnings
Cedar Woods reported presales of more than $788 million at 31 March 2026, with over 80% of forecast FY27 revenue already locked in. That is an unusually strong position heading into a softening enquiry environment.
The reason it matters is that the soft Q4 enquiry data the company flagged today has limited bearing on FY27 earnings. Those settlements are largely already sold. The enquiry softness becomes an FY28 problem, by which point the new Kealba and Fairfield pipeline starts feeding into the development cycle.
Management has also flagged FY27 will be H1 weighted, which gives the market an earlier-than-usual read on whether the trajectory holds. We would treat the first half FY27 result as the key validation point for the current strategy.
The risk sitting behind the disciplined acquisition story
The skeptical read is that buying when bidders thin out only looks smart in hindsight. If the housing cycle deteriorates further into FY27, the deferred settlements still need to be paid, and the Fairfield apartment site is subject to planning approvals that are not guaranteed.
Apartment development in particular has been a graveyard for ASX-listed developers over the past decade. A 500-plus apartment project across multiple stages in Brisbane is not a small bet, and execution risk on apartments has historically been higher than on land subdivision.
The structural housing undersupply argument the company makes is real. But undersupply does not automatically translate into sold stock at acceptable margins if mortgage serviceability tightens further.
The Investors Takeaway for Cedar Woods Properties
Cedar Woods is doing what well-capitalised developers are supposed to do in a soft market. It is buying pipeline while competitors cannot, structuring deferred terms that protect near-term cash, and leaning on an 80%-presold FY27 book to ride out the current enquiry weakness.
The investment debate from here is not about FY26. That number is effectively locked in at the top end of the 30% to 35% NPAT growth range. It is about whether the H1-weighted FY27 result confirms the company can convert presales into settlements without margin slippage, and whether Fairfield’s planning approvals land cleanly.
Investors looking for more ASX-listed property and development coverage can browse the latest pieces at stocksdownunder.
